Overview

Belatacept for Renal Transplant Recipients With Delayed Graft Function

Status:
Terminated

Trial end date:
2019-01-18

Target enrollment:

Participant gender:

Summary

Currently looking for individuals that have received a kidney transplant, are experiencing delayed graft function (DGF), and meet the criteria for study participation.

Phase:

Early Phase 1

Details

Lead Sponsor:

Ohio State University
Von Visger, Jon, MD

Collaborator:

Bristol-Myers Squibb

Treatments:

Abatacept
Everolimus
Sirolimus